Steven W. Schierholt, Esq. John R. Kasich
Executive Director Governor
77 South High Street, 17th Floor, Columbus, Ohio 43215
T: (614) 466.4143 | F: (614) 752.4836 | firstname.lastname@example.org | www.pharmacy.ohio.gov
Law Enforcement Agencies Seeking to Obtain Naloxone Hydrochloride (Narcan)
Per Ohio Revised Code Section 2925.61(D) a peace officer employed by a law enforcement agency is not
subject to administrative action or criminal prosecution if the peace officer, acting in good faith, obtains
naloxone from the peace officer's law enforcement agency and administers the naloxone to an individual
who is apparently experiencing an opioid-related overdose.
Per Ohio Revised Code Section 4729.51, as enacted by, a law enforcement agency is not subject to
licensure as a terminal distributor of dangerous drugs for the sole purpose of possessing naloxone. This
recent change permits law enforcement agencies to purchase naloxone from wholesalers or other terminal
distributors without a license by the State of Ohio Board of Pharmacy.
Please be advised that locations that operate correctional institutions and police dog trainers
are still required to obtain a terminal distributor of dangerous drugs (TDDD) license. The
agencies that have these existing TDDD licenses from the Board MAY have to submit additional
documentation to the Board (see FAQ 3) to purchase and store naloxone.
While you may not be required to obtain licensure to purchase naloxone, the State of Ohio Board of
Pharmacy strongly recommends the implementation of the following safeguards to ensure the safe use of
naloxone in the event of an opioid overdose:
STORAGE AND TEMPERATURE CONTROL
Naloxone should be stored at room temperature and away from light. According to the manufacturer, the
drug must be kept out of direct light and at room temperature (between 68 and 77 degrees Fahrenheit).
Please be aware that it should not be left in a car for extended periods of time and should not be
subjected to extreme heat or cold (it will freeze) as it may impact the effectiveness of the medication.
The shelf life of naloxone is approximately two years. All doses should be checked periodically to ensure
that the naloxone is not adulterated. A dose of naloxone is considered adulterated when:
a. It is beyond the manufacturers or distributors expiration date; and/or
b. There are signs of discoloration or particulate matter in the naloxone solution.
In order to keep track of expiration dates, law enforcement agencies should keep careful records of when
and to whom the medication was dispensed.
The State of Ohio Board of Pharmacy strongly encourages regular trainings on the administration of
naloxone in the event of an apparent opioid overdose. These training should consist of the following
standard overdose response components:
Recognizing the signs and symptoms of overdose
Distinguishing between different types of overdose
Performing rescue breathing
Administering intranasal naloxone
Such trainings can be conducted by your local EMS agency, emergency department personnel or a local
Project DAWN (Deaths Avoided with Naloxone) staff member. A list of the local Project DAWN sites can be
accessed here: http://www.healthy.ohio.gov/vipp/drug/ProjectDAWN.aspx
The Attorney General has also developed an eOPOTA naloxone training video for law enforcement is
accessible to officers via the Ohio Law Enforcement Gateway (OHLEG): https://www.ohleg.org/
In addition, the Ohio Department of Health has a number of training resources available on its web site:
Frequently Asked Questions
1) What is naloxone?
Naloxone (also known as Narcan) is a medication that can reverse an overdose that is caused by an opioid
drug (i.e. prescription pain medication or heroin). When administered during an overdose, naloxone blocks
the effects of opioids on the brain and restores breathing within two to eight minutes. Naloxone has been
used safely by emergency medical professionals for more than 40 years and has only one function: to
reverse the effects of opioids on the brain and respiratory system in order to prevent death. Naloxone has
no potential for abuse.
2) What type of naloxone can be administered by law enforcement in the event of a suspected
There are no restrictions on the formulations of naloxone that can be used by law enforcement. The
following are common methods of administering naloxone in the event of an overdose:
i) Intranasal naloxone (Naloxone Nasal Spray):
Naloxone 4mg/.1mL FDA approved nasal spray device, 2 doses per unit NDC No. 69547-353-
ii) Using a device manufactured for the intranasal administration of liquid drugs (i.e. a nasal
In order to administer naloxone via a nasal spray, a law enforcement agency will need to obtain the
Luer-Jet Luer-Lock Prefilled Syringe (2 mg / 2 mL of naloxone) NDC#: 76329-3369
MAD300 Nasal Atomization Device: This device can be ordered from a number of medical
supply companies without a prescription (it is NOT normally stocked at a local pharmacy).
The following provides an overview of how to assemble the nasal spray:
ii) Using an autoinjector in a manufactured dosage form (similar to an epi-pen)
On April 3, 2014, the U.S. Food and Drug Administration approved the first naloxone auto injector. To
read more about this product please visit:
Naloxone 0.4 mg/0.4 ml - NDC No. 60842-030-01
iii) Intramuscular injection using a syringe
Naloxone 0.4 mg/ml single dose vial, 2 vials
NDC No. 00409-1215-01
Syringe 3 ml 25G 1 inch No. 2
For more information on administering naloxone intramuscularly, please visit:
www.pharmacy.ohio.gov/naloxone and review the diagrams found in the Patient Counseling Brochure.
3) I already have a TDDD license for my agency? What do I need to do to obtain naloxone?
If you have an unlimited category II or category III TDDD license you are not required to do anything to
If your agency has a limited TDDD category II or III license, you will need to update your drug list to
reflect the addition of naloxone. The new drug list must contain the following information:
a) the brand name (Narcan)
b) the generic name (Naloxone)
c) strength to be stocked (Naloxone 2 mg / 2 mL)
d) dosage form (intranasal solution)
You can update your drug list by visiting: http://www.pharmacy.ohio.gov/Licensing/DrugList.aspx
BE ADVISED: Each time you revise your drug list you must upload your ENTIRE list. Previous versions
of your drug list will not be displayed on the website; they will be replaced with your most current
submissions once approved.
To check to see if your agency has a terminal distributor of dangerous drugs, please visit:
4) I want to order naloxone for my agency, where do I purchase it?
Naloxone can be obtained by three methods.
Wholesale Purchase: A law enforcement agency is permitted to order the drug from a wholesaler that
is licensed by the State of Ohio Board of Pharmacy. To verify a wholesale drug distributor is licensed in
Ohio, visit: www.pharmacy.ohio.gov/licenselookup
Wholesale Purchase from a Pharmacy: The State of Ohio Board of Pharmacy permits a pharmacy
licensed as a terminal distributor dangerous drugs to conduct an occasional sale of drugs at wholesale.
There are no restrictions on the amount that can be provided by a pharmacy to a law
enforcement agency pursuant to rule 4729-9-10.
The Ohio Department of Mental Health and Addiction Services operates Ohio Pharmacy Services, which
sells naloxone kits to local governments, including law enforcement. To contact Ohio Pharmacy Services,
please call: 614-752-0158.
Wholesale Purchase from a Local Health Department: The State of Ohio Board of Pharmacy also
permits a health department licensed as a terminal distributor dangerous drugs to provide naloxone at
wholesale to a law enforcement agency. Please be advised that the terminal distributor must properly
document the transaction (even if the health department is donating the naloxone). There are no
restrictions on the amount that can be provided by a health department to a law enforcement
The State of Ohio Board of Pharmacy strongly supports efforts to reduce opioid overdose death through
expanded use of naloxone. If you have any questions regarding the purchase, storage or use of naloxone,
please call us at 614-466-4143 or email us by visiting http://www.pharmacy.ohio.gov/Contact.aspx and
we will do everything we can to assist you.
5) Is there any financial assistance available for paying for the medication?
On March 2, 2015, Ohio Attorney General Mike DeWine and Amphastar Pharmaceuticals, Inc. entered into
an agreement where the drug manufacturer has agreed to provide a $6 rebate for each Amphastar
naloxone syringe purchased by certain Ohio public entities for the next year. A copy of that agreement can
be found at
www.OhioAttorneyGeneral.gov/AmphastarRebateAgreement. As part of the agreement, the Ohio Attorney
General has agreed to process all of the rebate requests. For more information about the rebate, please
The Ohio Mental Health and Addiction Services (OhioMHAS) is committing up to $500,000 in each state
fiscal year to enhance access to naloxone in every Ohio county. Funds allocated to the department will be
used to purchase naloxone, including complete Project DAWN Kits (Death Avoidance With Naloxone), for
distribution to county health departments to dispense to local law enforcement, emergency personnel and
first responders (as required by House Bill 64). For more information, please visit: